We performed GO analysis of downstream pathways and GSEA of these differentially expressed genes and found that ABCC5 highly expressed in prostate cancer may act through multiple tumor-related pathways, including the PI3K-Akt and MAPK/ERK signaling pathway and E2F target genes (Figure 4A-B). The gene discussed is AKT1; the disease is Familial prostate cancer.